Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions (Q79858864)
Jump to navigation
Jump to search
scientific article published on 06 July 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions |
scientific article published on 06 July 2006 |
Statements
Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions (English)
Luke PP
Deng JP
Lian D
O'Connell PJ
Garcia B
Jevnikar AM